Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial von Pavlakis, Nick, Sjoquist, Katrin M, Martin, Andrew J, Tsobanis, Eric, Yip, Sonia, Kang, Yoon-Koo, Bang, Yung-Jue, Alcindor, Thierry, O'Callaghan, Christopher J, Burnell, Margot J, Tebbutt, Niall C, Rha, Sun Young, Lee, Jeeyun, Cho, Jae-Yong, Lipton, Lara R, Wong, Mark, Strickland, Andrew, Kim, Jin Won, Zalcberg, John R, Simes, John, Goldstein, David

Volltext

Value of central review of RECIST v1.1 outcomes in the AGITG INTEGRATE randomised phase 2 international trial for advanced oesophago-gastric cancer von Sjoquist, Katrin M., Martin, Andrew, Pavlakis, Nick, Goldstein, David, Tsobanis, Eric, Moses, Daniel, Maher, Richard, Hague, Wendy, Gebski, Val, Stockler, Martin R., Simes, R. John

Volltext

Abstract 4531: SWATH-MS profiling identifies prognostic factors for progression-free survival (PFS) In INTEGRATE - A randomized phase II double-blind placebo-controlled study of re... von Hayes, Sarah A., Martin, Andrew, Yip, Sonia, Howell, Viive M., Sjoquist, Katrin M., Tsobanis, Eric, Kang, Yoon-Koo, Bang, Yung-Jue, Alcindor, Thierry, O'Callaghan, Christopher J., Tebbutt, Niall C., Simes, John, Goldstein, David, Pavlakis, Nick

Volltext

Randomised Phase 3 Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC) - INTEGRATE II von Chua, Yu Jo, Pavlakis, Nick, Sjoquist, Katrin M., Martin, Andrew J., Tsobanis, Eric, Yip, Sonia, Bang, Yung-Jue, Alcindor, Thierry, O’callaghan, Christopher J., Bekaii-Saab, Tanios S., Grothey, Axel, Chen, Li-Tzong, Simes, John, Zalcberg, John R., Goldstein, David, Komatsu, Yoshito, Machida, Nozomu, Esaki, Taito, Hara, Hiroki, Shitara, Kohei

Volltext

P2-228 [Encore]Randomised Phase 3 Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC) - INTEGRATE II von Chua, Yu Jo, Pavlakis, Nick, Sjoquist, Katrin M, Martin, Andrew J, Tsobanis, Eric, Yip, Sonia, Bang, Yung-Jue, Alcindor, Thierry, O’callaghan, Christopher J, Bekaii-Saab, Tanios S, Grothey, Axel, Chen, Li-Tzong, Simes, John, Zalcberg, John R, Goldstein, David, Komatsu, Yoshito, Machida, Nozomu, Esaki, Taito, Hara, Hiroki, Shitara, Kohei

Volltext

Integrate II: A randomised phase 3 double-blind placebo-controlled study of regorafenib in refractory advanced gastro-oesophageal cancer (AGOC)—An international study organized by... von Sjoquist, Katrin Marie, Pavlakis, Nick, Martin, Andrew James, Tsobanis, Eric, Yip, Sonia, Bang, Yung-Jue, Alcindor, Thierry, O'Callaghan, Christopher J., Shitara, Kohei, Bekaii-Saab, Tanios S., Grothey, Axel, Chen, Li-Tzong, Simes, John, Zalcberg, John Raymond, Goldstein, David

Volltext

Evaluation of circulating VEGF based biomarkers in INTEGRATE: A randomized phase II double-blind placebo-controlled study of regorafenib in refractory advanced oesophagogastric can... von Yip, Sonia, Harvie, Rozelle, Martin, Andrew James, Sjoquist, Katrin Marie, Tsobanis, Eric, Kang, Yoon-Koo, Bang, Yung-Jue, Alcindor, Thierry, O'Callaghan, Christopher J., Burnell, Margot J., Tebbutt, Niall C., Rha, Sun Young, Lee, Jeeyun, Cho, Jae Yong, Lipton, Lara Rachel, Strickland, Andrew, Zalcberg, John Raymond, Simes, John, Goldstein, David, Pavlakis, Nick

Volltext

INTEGRATE: A randomized, phase II, double-blind, placebo-controlled study of regorafenib in refractory advanced oesophagogastric cancer (AOGC): A study by the Australasian Gastroin... von Pavlakis, Nick, Sjoquist, Katrin Marie, Tsobanis, Eric, Martin, Andrew James, Kang, Yoon-Koo, Bang, Yung-Jue, O'Callaghan, Christopher J., Tebbutt, Niall C., Rha, Sun Young, Lee, Jeeyun, Cho, Jae Yong, Lipton, Lara Rachel, Burnell, Margot J., Alcindor, Thierry, Strickland, Andrew, Kim, Jin Won, Yip, Sonia, Simes, John, Zalcberg, John Raymond, Goldstein, David

Volltext

INTEGRATE: A randomized phase II double-blind placebo-controlled study of regorafenib in refractory advanced oesophagogastric cancer (AOGC)—A study by the Australasian Gastrointest... von Pavlakis, Nick, Sjoquist, Katrin Marie, Tsobanis, Eric, Martin, Andrew, Kang, Yoon-Koo, Bang, Yung-Jue, O'Callaghan, Christopher J., Tebbutt, Niall C., Rha, Sun Young, Lee, Jeeyun, Cho, Jae Yong, Lipton, Lara Rachel, Burnell, Margot J., Alcindor, Thierry, Strickland, Andrew, Wong, Mark, Kim, Jin Won, Simes, John, Zalcberg, John Raymond, Goldstein, David

Volltext

The NCIC CTG and AGITG CO.23 trial: A phase III randomized study of BBI608 plus best supportive care (BSC) versus placebo (PBO) plus BSC in patients (Pts) with pretreated advanced... von Jonker, Derek J., Nott, Louise M., Yoshino, Takayuki, Li, Chiang, Gill, Sharlene, Shapiro, Jeremy David, Ohtsu, Atsushi, Zalcberg, John Raymond, Vickers, Michael M., Simes, John, Wei, Alice Chia-chi, Mittmann, Nicole, Magoski, Nadine M, Murray, Yvonne, Tsobanis, Eric, Tu, Dongsheng, Kerstein, David, O'Callaghan, Christopher J.

Volltext

INTEGRATE: A randomized phase II double-blind placebo-controlled study of regorafenib in refractory advanced esophagogastric cancer (AOGC)—A study by the Australasian Gastrointesti... von Pavlakis, Nick, Goldstein, David, Sjoquist, Katrin Marie, Martin, Andrew, Tsobanis, Eric, Yip, Sonia, Shannon, Jenny, Burge, Matthew E., Cronk, Michelle F., Tebbutt, Niall C., Strickland, Andrew, Lipton, Lara Rachel, Price, Timothy Jay, Nott, Louise M., Harris, Dean Laurence, Burnell, Margot J., Alcindor, Thierry, Bang, Yung-Jue, Kang, Yoon-Koo, O'Callaghan, Christopher J.

Volltext